Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03995355 · ClinicalTrials.gov registry record
Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients
A clinical trial, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- 161
- Enrollment target
NCT03995355: Completed study, sponsored by Johnson & Johnson Vision Care.
NCT03995355 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03995355 has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- 161 participants
- Enrollment target
Study Summary
This is a double-masked, randomized, bilateral, 2-Arm parallel group study. Subjects are scheduled for 3 study visits (screening/baseline, 7-Day and 30-Day follow-up visits) over a period of one month.
Primary Outcome
Subjective overall ocular comfort was assessed at baseline, and at the 30-Day follow-up using a Visual Analogue Scale (VAS) ranging from 0 (extremely uncomfortable) to 100 (extremely comfortable). The change from baseline ocular comfort score was calculated as 30-Day follow-up score minus Baseline score. Change from Baseline VAS Scores range from -100 to 100, where higher change from baseline comfort scores indicates better performance. The average change from baseline comfort score for each Arm
Interventions
- DEVICE 9618X investigational lipid eye drops
- DEVICE Blink® Tears
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 161 participants |
| Start Date | 2019-06-26 |
| Est. Completion | 2019-09-20 |
What the finished NCT03995355 record still lists
NCT03995355 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which 9618X investigational lipid eye drops is the first listed.
NCT03995355 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03995355 about?
NCT03995355 is a clinical study titled "Clinical Evaluation of an Investigational Lipid Drop in Non-contact Lens Wearing Patients". This is a double-masked, randomized, bilateral, 2-Arm parallel group study. Subjects are scheduled for 3 study visits (screening/baseline, 7-Day and 30-Day follow-up visits) over a period of one month.
What is the current status of trial NCT03995355?
This trial is currently completed. The enrollment target is 161 participants. The study started on 2019-06-26. Estimated completion is 2019-09-20.
What interventions are being tested in trial NCT03995355?
The interventions under investigation include: 9618X investigational lipid eye drops (DEVICE), Blink® Tears (DEVICE).
Who is sponsoring clinical trial NCT03995355?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06391034 · 161 participants · Phase 2
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
- NCT06546670 · 161 participants · Phase 1
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- NCT06616766 · 161 participants · Phase 1
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- NCT06752356 · 161 participants · Phase 3
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI